Degradation of the polysaccharide component of gonococcal lipopolysaccharide by gonococcal and meningococcal sonic extracts
- PMID: 78894
- PMCID: PMC421576
- DOI: 10.1128/iai.20.1.228-234.1978
Degradation of the polysaccharide component of gonococcal lipopolysaccharide by gonococcal and meningococcal sonic extracts
Abstract
An extract made from the supernatant of Neisseria gonorrhoeae Gc2 strain 1291 degraded the Gc2 polysaccharide antigen. Chemical analysis of this polysaccharide indicated it contains glucose, galactose, glucosamine, galactosamine, glucosamine-6-phosphate, heptose, 2-keto-3-deoxyotonate, and ethanolamine and is the polysaccharide component of gonococcal lipopolysaccharide. Degradation of the polysaccharide by sonic extracts resulted either in complete loss of antigenicity and immunogenicity or in partial degradation to subunits that could inhibit the Gc2-specific hemagglutination inhibition. The factors responsible for degradation were destroyed by heating at 100 degrees C for 5 min or by Pronase digestion, but were unaffected by ribonuclease, deoxyribonuclease, Mg2+, Ca2+, or ethylenediaminetetraacetic acid. The process was pH dependent, with optimal activity occurring at pH 7. Sonic extract supernatants from group B and C meningococcal strains contained degrading properties, whereas similar extracts produced from Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Streptococcus pneumoniae type II failed to degrade the Gc2 polysaccharide.
Similar articles
-
Lipopolysaccharide-derived serotype polysaccharides from Neisseria meningitidis group B.J Infect Dis. 1979 Jul;140(1):62-72. doi: 10.1093/infdis/140.1.62. J Infect Dis. 1979. PMID: 88491
-
Monoclonal antibody analysis of lipopolysaccharide from Neisseria gonorrhoeae and Neisseria meningitidis.Infect Immun. 1981 Dec;34(3):751-6. doi: 10.1128/iai.34.3.751-756.1981. Infect Immun. 1981. PMID: 6174450 Free PMC article.
-
The oligosaccharide of gonococcal lipooligosaccharide contains several epitopes that are recognized by human antibodies.Infect Immun. 2010 Jul;78(7):3247-57. doi: 10.1128/IAI.01445-09. Epub 2010 May 17. Infect Immun. 2010. PMID: 20479085 Free PMC article.
-
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.Mol Immunol. 1999 Sep-Oct;36(13-14):915-28. doi: 10.1016/s0161-5890(99)00114-5. Mol Immunol. 1999. PMID: 10698346 Review.
-
Neisseria proteomics for antigen discovery and vaccine development.Expert Rev Proteomics. 2014 Oct;11(5):573-91. doi: 10.1586/14789450.2014.938640. Epub 2014 Jul 12. Expert Rev Proteomics. 2014. PMID: 25017717 Review.
Cited by
-
DNA uptake sequence-mediated enhancement of transformation in Neisseria gonorrhoeae is strain dependent.J Bacteriol. 2010 Sep;192(17):4436-44. doi: 10.1128/JB.00442-10. Epub 2010 Jul 2. J Bacteriol. 2010. PMID: 20601472 Free PMC article.
-
Effect of dilution rate on lipopolysaccharide and serum resistance of Neisseria gonorrhoeae grown in continuous culture.Infect Immun. 1983 Jul;41(1):74-82. doi: 10.1128/iai.41.1.74-82.1983. Infect Immun. 1983. PMID: 6408006 Free PMC article.
-
The Neisseria gonorrhoeae Methionine Sulfoxide Reductase (MsrA/B) Is a Surface Exposed, Immunogenic, Vaccine Candidate.Front Immunol. 2019 Feb 6;10:137. doi: 10.3389/fimmu.2019.00137. eCollection 2019. Front Immunol. 2019. PMID: 30787927 Free PMC article.
-
The Neisseria gonorrhoeae Obg protein is an essential ribosome-associated GTPase and a potential drug target.BMC Microbiol. 2015 Jun 30;15:129. doi: 10.1186/s12866-015-0453-1. BMC Microbiol. 2015. PMID: 26122105 Free PMC article.
-
Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.Mol Cell Proteomics. 2016 Jul;15(7):2338-55. doi: 10.1074/mcp.M116.058800. Epub 2016 May 2. Mol Cell Proteomics. 2016. PMID: 27141096 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous